Development of Patients Reported Outcome of Crohn's disease:prospective multicenter cohort study

Development of Patients Reported Outcome of Crohn's disease:prospective multicenter cohort study - PROCD study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022245

Enrollment

100

Registered

2016-05-09

Start date

2016-04-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: CDAI>=220

Exclusion criteria

Exclusion criteria: CDAI<220 Past history of anti TNF alpha treatment

Design outcomes

Primary

Measure	Time frame
Remission after 14 weeks from the start of anti TNF alpha	—

Secondary

Measure	Time frame
CDAI(6 and 14 weeks), CRP(6 and 14 weeks) EQ-5D-3L(1,2,4,8 and 12 weeks),QALY	—

Countries

Japan

Contacts

Public ContactMasayasu Horibe

Keio University School of Medicine Division of Gastroenterology and Hepatology Department of Internal Medicine

masayasu-horibe@umin.ac.jp+81-3-5363-3790

Outcome results